Figures & data
Table 1 Comparison of the average dose delivered to levels I–III in the standard and the high tangential irradiation fields
Figure 1 Combined hypothetical benefit of local tumor control on survival with increasing effectiveness of systemic therapy (ST) and decreasing risk of distant metastases of the primary tumor.
Notes: Patients in the left part of the slope have high-risk disease without effective systemic therapy and are not expected to benefit from improving locoregional treatments. For patients in the right part of the slope, treatment deintensification (surgery, radiation, or systemic therapy) might be appropriate. The middle group will represent most past and current patients with breast cancer, for whom an optimum multidisciplinary approach results in the greatest benefit.
